Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Weisan Chen

Showing results (131-140 of 175) with videos related to

Pageof 18
Sort By:
Cancer Immunology, Immunotherapy : CII|June 24, 2011
Immunoediting and persistence of antigen-specific immunity in patients who have previously been vaccinated with NY-ESO-1 protein formulated in ISCOMATRIX™Theo Nicholaou, Weisan Chen, Ian D Davis, et al.
Immunity|June 14, 2008
The exception that reinforces the rule: crosspriming by cytosolic peptides that escape degradationAvital Lev, Kazuyo Takeda, Damien Zanker, et al.
Pharmacological Research|March 1, 2024
CD39<sup>hi</sup> identifies an exhausted tumor-reactive CD8<sup>+</sup> T cell population associated with tumor progression in human gastric cancerYang Shen, Yuan Qiu, Zhen-Quan Duan, et al.
Mbio|October 29, 2015
Inactivated Influenza Vaccine That Provides Rapid, Innate-Immune-System-Mediated Protection and Subsequent Long-Term Adaptive ImmunityBrendon Y Chua, Chinn Yi Wong, Edin J Mifsud, et al.
Journal for Immunotherapy of Cancer|February 28, 2019
Increased intratumoral mast cells foster immune suppression and gastric cancer progression through TNF-α-PD-L1 pathwayYipin Lv, Yongliang Zhao, Xianhua Wang, et al.
Immunotherapy|February 11, 2017
A pilot study of peripheral blood BDCA-1 (CD1c) positive dendritic cells pulsed with NY-ESO-1 ISCOMATRIX™ adjuvantIan D Davis, Juliet Quirk, Leone Morris, et al.
Cancer Research|January 30, 2009
A long, naturally presented immunodominant epitope from NY-ESO-1 tumor antigen: implications for cancer vaccine designLisa M Ebert, Yu Chih Liu, Craig S Clements, et al.
Oncotarget|July 14, 2016
Altered phenotypic and functional characteristics of CD3+CD56+ NKT-like cells in human gastric cancerLiu-Sheng Peng, Fang-Yuan Mao, Yong-Liang Zhao, et al.
Cancer Immunology Research|February 3, 2017
Tumor-Associated Monocytes/Macrophages Impair NK-Cell Function via TGFβ1 in Human Gastric CancerLiu-Sheng Peng, Jin-Yu Zhang, Yong-Sheng Teng, et al.
Journal of Virology|November 15, 2013
Inosine-mediated modulation of RNA sensing by Toll-like receptor 7 (TLR7) and TLR8Soroush T Sarvestani, Michelle D Tate, Jessica M Moffat, et al.
Pageof 18

Showing results (131-140 of 175) with videos related to

Sort By:
Pageof 18
Cancer Immunology, Immunotherapy : CII|June 24, 2011
Immunoediting and persistence of antigen-specific immunity in patients who have previously been vaccinated with NY-ESO-1 protein formulated in ISCOMATRIX™Theo Nicholaou, Weisan Chen, Ian D Davis, et al.
Immunity|June 14, 2008
The exception that reinforces the rule: crosspriming by cytosolic peptides that escape degradationAvital Lev, Kazuyo Takeda, Damien Zanker, et al.
Pharmacological Research|March 1, 2024
CD39<sup>hi</sup> identifies an exhausted tumor-reactive CD8<sup>+</sup> T cell population associated with tumor progression in human gastric cancerYang Shen, Yuan Qiu, Zhen-Quan Duan, et al.
Mbio|October 29, 2015
Inactivated Influenza Vaccine That Provides Rapid, Innate-Immune-System-Mediated Protection and Subsequent Long-Term Adaptive ImmunityBrendon Y Chua, Chinn Yi Wong, Edin J Mifsud, et al.
Journal for Immunotherapy of Cancer|February 28, 2019
Increased intratumoral mast cells foster immune suppression and gastric cancer progression through TNF-α-PD-L1 pathwayYipin Lv, Yongliang Zhao, Xianhua Wang, et al.
Immunotherapy|February 11, 2017
A pilot study of peripheral blood BDCA-1 (CD1c) positive dendritic cells pulsed with NY-ESO-1 ISCOMATRIX™ adjuvantIan D Davis, Juliet Quirk, Leone Morris, et al.
Cancer Research|January 30, 2009
A long, naturally presented immunodominant epitope from NY-ESO-1 tumor antigen: implications for cancer vaccine designLisa M Ebert, Yu Chih Liu, Craig S Clements, et al.
Oncotarget|July 14, 2016
Altered phenotypic and functional characteristics of CD3+CD56+ NKT-like cells in human gastric cancerLiu-Sheng Peng, Fang-Yuan Mao, Yong-Liang Zhao, et al.
Cancer Immunology Research|February 3, 2017
Tumor-Associated Monocytes/Macrophages Impair NK-Cell Function via TGFβ1 in Human Gastric CancerLiu-Sheng Peng, Jin-Yu Zhang, Yong-Sheng Teng, et al.
Journal of Virology|November 15, 2013
Inosine-mediated modulation of RNA sensing by Toll-like receptor 7 (TLR7) and TLR8Soroush T Sarvestani, Michelle D Tate, Jessica M Moffat, et al.
Pageof 18